CHD5 and central nervous system cancer: We further explored whether CHD5 expression was dependent on the CNV status in the 32 types of cancers, and found statistically significant differences in 9 types of cancers (Figure 4B), including GBM (p = 0.02), Glioma (p = 5.1 × 10−5, ESCA (p = 4.6 × 10−3), STES (p = 5.6 × 10−4), KIRP (p = 0.02), KIPAN (p = 0.04), TGCT (p = 0.03), PCPG (p = 0.05) and ACC (p = 0.04).